2022

Professional development Vacancies
2022
Regarding amendments to the package insert for medicinal products containing olmesartan, including fixed-dose combinations

Based on a review of the available data from EudraVigilance and the literature, the Pharmacovigilance Risk Assessment Committee (PRAC) considers that the degree…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing spironolactone

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the analysis of Periodic Safety Update Reports (PSURs) for medicinal products that…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing dexamethasone (dexamethasone)

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the analysis of Periodic Safety Update Reports (PSURs) for medicinal products that…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing ondansetron (ondansetron)

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the assessment of the analysis of Periodic Safety Update Reports (PSURs) for medicinal products,…

Read more